Melanoma Clinical Trial

Pan Tumor Nivolumab Rollover Study

Summary

Main Objective of this study is to examine long-term safety of nivolumab in participants on treatment and in follow up.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria: -

Signed Written Informed Consent
Participants who have completed treatment with nivolumab, progressed on prior nivolumab treatment or discontinued nivolumab due to toxicity in the Parent Study are not eligible to receive nivolumab in this study. These participants may be enrolled for safety and survival follow-up only.
Participant is eligible for nivolumab treatment as per the Parent Study, and/or Investigator assessed clinical benefit, or
Participant is in or has completed the follow-up phase of the Parent Study i) Participant has completed or discontinued treatment, or ii) Participant has progressed on treatment, and/or iii) Participant is on subsequent therapy Exclusion Criteria: -
Participant is not eligible for nivolumab treatment as per the Parent Study
Participants not receiving clinical benefit as assessed by the Investigator (participant is still eligible for study if entering survival follow-up only)
Any clinical adverse event (AE), laboratory abnormality, or intercurrent illness which, in the opinion of the Investigator, indicates that participation in the study is not in the best interest of the participant
Participants in survival follow-up have no exclusion criteria.

Study is for people with:

Melanoma

Phase:

Phase 2

Estimated Enrollment:

800

Study ID:

NCT03899155

Recruitment Status:

Recruiting

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 242 Locations for this study

See Locations Near You

How clear is this clinincal trial information?

Study is for people with:

Melanoma

Phase:

Phase 2

Estimated Enrollment:

800

Study ID:

NCT03899155

Recruitment Status:

Recruiting

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.